APA (7th ed.) Citation

Guleria, K., Sood, R., Goel, H., Sharma, U., & Singla, A. (2022). 138MO A randomized study to compare outcomes of intravesical chemohyperthermia with mitomycin C vs intravesical BCG for intermediate and high risk non-muscle invasive bladder cancer (NMIBC). Annals of Oncology, 33, S1486. https://doi.org/10.1016/j.annonc.2022.10.173

Chicago Style (17th ed.) Citation

Guleria, K., R. Sood, H. Goel, U. Sharma, and A. Singla. "138MO A Randomized Study to Compare Outcomes of Intravesical Chemohyperthermia with Mitomycin C Vs Intravesical BCG for Intermediate and High Risk Non-muscle Invasive Bladder Cancer (NMIBC)." Annals of Oncology 33 (2022): S1486. https://doi.org/10.1016/j.annonc.2022.10.173.

MLA (9th ed.) Citation

Guleria, K., et al. "138MO A Randomized Study to Compare Outcomes of Intravesical Chemohyperthermia with Mitomycin C Vs Intravesical BCG for Intermediate and High Risk Non-muscle Invasive Bladder Cancer (NMIBC)." Annals of Oncology, vol. 33, 2022, p. S1486, https://doi.org/10.1016/j.annonc.2022.10.173.